Health and Health Commission issues management measures for medical representative visits

In the era of the savage growth of the pharmaceutical market, pharmaceutical representatives traveled through the net of interests generated by disorderly competition and became the most active and cutting-edge elements in the circulation field

However, policies such as the "two-invoice system", consistent evaluation, and volume-based procurement have been implemented successively.

The first provincial medical representative measures released

On January 10, the Jiangxi Health and Health Commission issued the "Notice on Printing and Distributing the Management Measures for Medical Representatives Visiting Staff in Medical Institutions (2021)" (hereinafter referred to as the "Measures"), which is the first provincial-level guideline for medical representative visits.

The "Measures" aim to further strengthen the construction of the industry >

The medical representatives mentioned in the document refer to the staff (engineering installation and maintenance personnel, tenderers, etc.

The "Measures" put forward a number of key requirements for the visit of medical representatives:

▍Key point 1: It is necessary to register and file in the medical institution, at least once a year

Medical representatives who carry out academic and commercial promotion activities for related products in medical institutions should first register and file with the functional departments of pharmaceuticals, medical devices, medical consumables and other functional departments of the medical institution, and report to the medical ethics department for unified management

The registration and filing of medical representatives in medical institutions shall include the following items:

Original Power of Attorney signed or stamped by the legal representative of the production and operation enterprise of medicines, medical devices, medical consumables, etc.

▍Key point 2: Those who have not made an appointment will not be accepted

Medical institutions should establish a reception day management system and implement appointment reception.

Medical institutions should fix the day for the collective reception of medical representatives, specify the fixed reception location, determine the reception staff according to the appointment situation, improve the reception process, and keep records of reception

The medical representative must make an appointment with the staff of the medical ethics department or the relevant functional department in advance, and the medical institution shall review their identity

▍Key point 3: It is strictly forbidden for hospital staff to contact medical representatives in medical institutions without authorization

Medical representatives can only go to the medical institution to carry out academic promotion and commercial promotion activities on the reception day.

Without permission, medical representatives are not allowed to carry out business activities in medical institutions

▍Key point 4: Establish integrity record files and check from time to time

Each medical institution shall establish a file of integrity records of pharmaceutical production and operation enterprises to record the integrity and compliance behaviors and violations of relevant enterprises in their institutions

The medical ethics and medical ethics department of each medical institution should work with relevant functional departments to conduct inspections in clinical, medical and technical departments and relevant functional departments from time to time.

▍Important 5: Rebates shall not be given in any name or form

Medical representatives shall not carry out business activities in violation of laws and regulations, shall not give rebates to medical institution staff (including their close relatives and other specific related persons) in any name or form, and shall not entrust technicians, installation and maintenance personnel, etc.

▍Key 6: Limitation of offenders, suspension of purchases, transfer to justice

If a medical representative violates the relevant provisions of these Measures, the enterprise shall apply for listing as a bad record of commercial bribery in the field of pharmaceutical purchase and sales in Jiangxi Province, and the medical institution shall, depending on the circumstances, give the enterprise involved a limited amount of relevant product purchases, terminate the cooperative relationship with it, etc.

Medical staff of various medical institutions who violate the regulations and privately contact medical representatives in their own institutions shall be included in the management of bad practice behavior of medical staff
.
If there are violations of regulations and disciplines, they will be transferred to the discipline inspection and supervision department for handling; those suspected of violating the law will be transferred to the judicial department
.

The health authorities at all levels shall strengthen the supervision and inspection of the implementation of these measures by the medical institutions and their staff within their respective jurisdictions according to their management authority
.

Relevant industry organizations in the field of pharmaceutical purchase and sales shall cooperate with the competent health authorities in the implementation of these Measures in accordance with their own responsibilities, and strengthen industry self-discipline
.

The shuffling war in the pharmaceutical industry has changed the demand profile of many segmentation factors, and pharmaceutical representatives are one of them
.
From disorderly mixing to systematic governance, medical representatives are reborn in a "butterfly change"
.

Attached is the full text of the "Notice on Printing and Distributing the Administrative Measures for Visiting Staff in Medical Representatives' Medical Institutions (2021)":